Arterial stiffness and influences of the metabolic syndrome: A cross-countries study by Scuteri, A. (Angelo) et al.
lable at ScienceDirect
Atherosclerosis 233 (2014) 654e660Contents lists avaiAtherosclerosis
journal homepage: www.elsevier .com/locate/atherosclerosisArterial stiffness and influences of the metabolic syndrome:
A cross-countries study
Angelo Scuteri a,*, Pedro G. Cunha b,c,d, E. Agabiti Rosei e, Jolita Badariere f,g, Sofie Bekaert h,
John R. Cockcroft i, Jorge Cotter b,c,d, Francesco Cucca j, Marc L. De Buyzere v,
Tim De Meyer k, Luigi Ferrucci l, Osca Francom, Nichols Gale i, Thierry C. Gillebert v,
A. Hofmanm, Michel Langlois n, Aleksandras Laucevicius f,g, Stephane Laurent o,
Francesco U.S. Mattace Rasom, Cristopher H. Morrell p,q, Maria Lorenza Muiesan e,
Margaret M. Munnery i, Rokas Navickas f,g, Pedro Oliveira r, Marco Orru’ j,
Maria Grazia Pilia j, Ernst R. Rietzschel v, Ligita Ryliskyte f,g, Massimo Salvetti e,
David Schlessinger s, Nuno Sousa c,d, Christodoulos Stefanadis t, James Strait p,
Caroline Van daele v, Isabel Villa b, Charalambos Vlachopoulos t, Jacqueline Wittemanm,
Panagiotis Xaplanteris t, Peter Nilsson u, Edward G. Lakatta p,
For the MARE Consortium
a San Raffaele Pisana (HSR) IRCCS, Rome, Italy
bCenter for the Research and Treatment of Arterial Hypertension and Cardiovascular Risk, Internal Medicine Department, Guimarães, Centro Hospitalar do
Alto Ave/Minho University, Guimaraes Braga, Portugal
c Life and Health Science Research Institute (ICVS), School of Health Science, University of Minho, Guimaraes Braga, Portugal
d ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
eDipartimento di Scienze Cliniche e Sperimentali, Università di Brescia, 2 Medicina Generale Spedali Civili, Brescia, Italy
fClinic of Cardiovascular Diseases, Medical Faculty, Vilnius University, Vilnius, Lithuania
gCentre of Cardiology and Angiology, Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania
hBimetra, Clinical Research Center Ghent, Ghent University Hospital, Ghent, Belgium
iWales Heart Research Institute, Cardiff University, Heath Park, Cardiff, UK
j Institute of Genetics and Biomedic Research (IRGB), Consiglio Nazionale delle Ricerche, Monserrato, Cagliari, Italy
kDept. of Mathematical Modelling, Statistics and Bioinformatics, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium
l Scientific Director, IRP NIA, NIH, Baltimore, USA
mDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
nClinical Chemistry, AZ Sint-Jan Bruges Hospital, Asklepios Core Lab, and Department of Cardiovascular Diseases, Ghent University, Ghent, Belgium
oDepartment of Pharmacology, Pompidou Hospital, INSERM U970 and University Paris Descartes, Paris, France
p Laboratory Cardiovascular Sciences, National Institute on Aging (NIA), NIH, Baltimore, USA
q Loyola College, Baltimore, USA
rDepartamento de Estudo de Populações, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
s Laboratory of Genetics, National Institute on Aging (NIA), NIH, Baltimore, USA
t1st Department of Cardiology, Athens Medical School, Athens, Greece
uDepartment of Clinical Sciences, Lund University, University Hospital, Malmö, Sweden
vDepartment of Cardiovascular Diseases, Ghent University Hospital and Ghent University, Ghent, Belgiuma r t i c l e i n f o
Article history:
Received 14 October 2013
Received in revised form
18 January 2014
Accepted 19 January 2014
Available online 30 January 2014* Corresponding author.
E-mail address: angeloelefante@interfree.it (A. Scu
0021-9150/$ e see front matter  2014 Elsevier Irela
http://dx.doi.org/10.1016/j.atherosclerosis.2014.01.041a b s t r a c t
Specific clusters of metabolic syndrome (MetS) components impact differentially on arterial stiffness,
indexed as pulse wave velocity (PWV). Of note, in several population-based studies participating in the
MARE (Metabolic syndrome and Arteries REsearch) Consortium the occurrence of specific clusters of
MetS differed markedly across Europe and the US. The aim of the present study was to investigate
whether specific clusters of MetS are consistently associated with stiffer arteries in different populations.
We studied 20,570 subjects from 9 cohorts representing 8 different European countries and the US
participating in the MARE Consortium. MetS was defined in accordance with NCEP ATPIII criteria as theteri).
nd Ltd. All rights reserved.
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Characteristic of cohorts participating the MARE Cons
Asklepios BL
N 2044 12
Age (years) 51.0  12.5 65
Men (%) 52.6 50
Waist (cm) 88.9  13.4 91
BMI (Kg/m2) 26.3  4.5 27
Glucose (mg/dl) 93.7  16.9 92
Tot cholesterol (mg/dl) 213.3  37.6 19
LDL cholesterol (mg/dl) 129.2  34.4 11
HDL cholesterol (mg/dl) 62.3  17.3 58
Triglycerides (mg/dl) 111.4  79.7 10
SBP (mmHg) 129.9  17.3 11
DBP (mmHg) 79.8  10.3 66
Hypertension (%) 32.4 36
Diabetes mellitus (%) 4.7 8.
Antihypertensive medication (%) 10.5 4.
PWV (m/sec) 6.6  1.5 7.simultaneous alteration in 3 of the 5 components: abdominal obesity (W), high triglycerides (T), low
HDL cholesterol (H), elevated blood pressure (B), and elevated fasting glucose (G). PWV measured in each
cohort was “normalized” to account for different acquisition methods.
MetS had an overall prevalence of 24.2% (4985 subjects). MetS accelerated the age-associated increase
in PWV levels at any age, and similarly in men and women. MetS clusters TBW, GBW, and GTBW are
consistently associated with significantly stiffer arteries to an extent similar or greater than observed in
subjects with alteration in all the five MetS components e even after controlling for age, sex, smoking,
cholesterol levels, and diabetes mellitus e in all the MARE cohorts.
In conclusion, different component clusters of MetS showed varying associations with arterial stiffness
(PWV).
 2014 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Stiffening of the central arteries beyond age of 40 years is a
characteristic feature of advancing aging [1]. Aortic stiffness is now
considered a useful proxy of arterial aging, and can be accurately
and non-invasively indexed as pulse wave velocity (PWV) [2,3].
Additionally, PWV is an independent risk factor for cardiovascular
(CV) events and cognitive impairment, even when the impact of
chronological age, blood pressure and other known CV risk factors
are taken into account [4e10].
Arterial aging is not exclusively a characteristic of older subjects,
but begins early in life, as the conceptualization of early vascular
aging (EVA) notes [11].
Even though the metabolic syndrome (MetS) remains a
controversial entity [12], it has previously been shown to be
associated with higher odds of CV events in middle-age and older
subjects [13e17]. It has been reported that MetS is associated
with alteration in the arterial system [18e20] and with inflam-
mation [21e23]. In a general population, we have previously
described that MetS accelerates arterial aging [24,25]. Notably,
specific clusters of MetS components impacted differentially on
arterial abnormalities [25]. Specifically, the cluster of elevated
triglycerides, elevated blood pressure, and abdominal obesity as
well as the cluster of elevated glucose, elevated triglycerides,
elevated blood pressure, and abdominal obesity were associated
with two-fold higher odds ratio of presenting extremely stiff ar-
teries, after controlling for age, sex, and occurrence of diabetes
mellitus [25].
Recently, we also reported that the occurrence of specific clus-
ters of MetS differed markedly across Europe and US [26] and in a
gender-specific manner. These results further supported the idea
that what is included under the current definition of MetS rather
represents a constellation of different phenotypes. In such a
context, it is critical to determine whether the groupings ofortium with available PWV measu
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6  1.9 7.5  2.3 8.4  1phenotypes falling under the common definition of MetS impose
an equal burden on arterial stiffness or not.
Therefore, the aim of the present cross-sectional, observational
study was to investigate whether specific clusters of MetS are
consistently associated with stiffer arteries in different populations
from 20,570 subjects recruited from nine cohorts representing
eight different European countries and the US participating in the
MARE (Metabolic syndrome and Arteries REsearch) Consortium.
Additionally, we investigated whether this association differed in
men and women.
2. Methods
2.1. The MARE Consortium
The original MARE (Metabolic syndrome and Artery REsearch)
Consortium was established as a collaboration among eleven Eu-
ropean and one American centre studying population-based co-
horts to identify any cross-cultural differences in clustering of MetS
altered components and associations with arterial aging; to
disentangle the specific role of genes and lifestyle factors (and their
interactions) on the clinical presentation of MetS and on the CV risk
attributable to MetS; and to develop new strategies to prevent CV
events through identification of lifestyle changes (see reference 26
for more details).
The MARE Consortium is open to additional participating co-
horts, provided that data on the MetS components and on arterial
properties become available for the recruited subjects.
Each study had been approved by local Institutional Review
Board or Ethica Committee and each subject gave informed con-
sent. All studies participating in the MARE Consortium adhere to
the principles of the Declaration of Helsinki and Title 45, U.S. Code
of Federal Regulations, Part 46, Protection of Human Subjects,
Revised November 13, 2001, effective December 13, 2001.rements.
LitHiR Rotterdam SardiNIA SMART Vobarno
2948 3445 6022 476 385
13.0 54.4  6.1 73.3  7.7 43.7  17.6 62.2  11.2 56.5  9.7
65.3 59.9 57.5 55.1 56.1
13.0 105.2  10.9 93.5  11.6 84.8  13.1 96.0  13.8 89.8  11.8
4.6 31.7  5.0 26.8  4.0 25.4  4.7 28.1  5.1 25.7  3.9
19.7 111.5  24.6 106.8  26.6 90.1  23.6 101.2  20.7 99.0  20.8
38.2 264.2  58.6 225.0  38.1 208.6  42.2 195.5  41.9 214.5  34.5
33.9 171.6  50.6 N/A 127.0  35.0 110.4  41.7 135.3  33.2
12.1 50.3  12.5 53.9  15.4 64.2  14.9 52.1  19.5 57.1  14.4
70.0 214.3  232.3 134.7  67.0 85.2  52.7 142.9  85.0 127.3  90.0
18.3 139.6  16.1 143.6  21.3 125.9  18.5 133.4  22.6 137.3  14.8
12.4 85.8  9.5 75.3  11.2 77.6  10.5 77.0  8.3 85.9  7.3
93.7 N/A 25.5 47.0 62.9
21.8 15.4 4.9 4.5
N/A 39.6 9.7 N/A 33.6
.9 8.8  1.6 10.6  2.4 6.7  2.3 9.2  2.2 9.1  2.1
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described in Supplemental Material.
2.2. Definition of the metabolic syndrome
The Third Report of the National Cholesterol Education Program
Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (ATPIII) [27] defined the MetS as an alteration
in three or more of the following five components: abdominal
obesity (W), high triglycerides (T), low HDL cholesterol (H),
elevated blood pressure (systolic or diastolic) (B), and elevated
fasting glucose (G). The following cut-off values are used to define
each altered component: waist circumference >102 cm for men or
>88 cm for women, triglycerides 150 mg/dl HDL cholesterol
<40 mg/dl for men or <50 mg/dl for women, blood pressure130/
85 mmHg, and fasting glucose 110 mg/dl.
BecauseMetS is defined by the presence of three ormore altered
components, subjects with MetS may have different combinations
of the individual components of MetS.
2.3. PWV measurements
PWV was measured non-invasively and calculated from foot-
to-foot delay between carotid and femoral waveforms and body
surface measurement of the distance between carotid and
femoral pulse recording site [2]. Differences in the method used
to ascertain transit distance or in the algorithm adopted to enter
transit distance into PWV calculation can alter values by up to
30% [28]. Therefore, in accordance with recent recommenda-
tions [29], PWV measured in each cohort was “normalized” as
follows:
For devices entering the direct distance (common carotid ar-
teryecommon femoral artery):
PWV “normalized” ¼ PWV measured  0.8.for devices entering
the subtracted distance (common carotid artery-common femoral
artery):
PWV “normalized” ¼ PWV measured.
2.4. Statistical analysis
All analyses were performed using the SAS package for Win-
dows (9.1 Version Cary, NC, USA). ANOVA analysis followed by
Bonferroni test was adopted to comparemeans amongst subgroups
of subjects. Least square means (standard error, SEM) were
calculated with ANCOVA analysis in order to compare PWV and
blood pressure values across clusters of MetS components, after
controlling for covariates (age, sex, non-HDL cholesterol levels,
current smoking, presence of diabetes mellitus, and study site for
PWV). To test for possible age- or sex-specific differences in PWV
values across MetS clusters, interaction terms for study site, sex,
and MetS clusters or study site, age, and MetS clusters were
introduced into separate models.
Multivariable logistic regression analysis was used to identify
which clusters of MetS components were significant determinants
of extremely stiff arteries. For the primary analysis, extreme stiff
arteries were defined based upon the 95th percentile of PWV dis-
tribution within each cohort. Confirmatory analysis was conducted
using the 95th percentile of PWV distribution in the whole popu-
lation. Age, sex, non-HDL cholesterol levels, current smoking status,
presence of diabetes mellitus, and study site were introduced as
covariates. Secondary analyses were run adding use of antihyper-
tensive medications as covariate.
Additional models were run in men and women, and in younger
and older (>65 years) subjects, separately.
A two-sided p value <0.05 indicated statistical significance.3. Results
Complete datawere available for 20,570 subjects (9034men and
11,546 women), whose characteristics are briefly summarized in
Table 1. MetS had an overall prevalence of 24.2% (4985 subjects).
PWV increased significantly with age and was higher in men than
in women.3.1. Effects of specific clusters of MetS components on arterial
stiffness across populations in the MARE Consortium
After controlling for age, sex, non-HDL cholesterol, smoking,
diabetes mellitus, and Study center, any cluster of MetS compo-
nents in the whole population was associated on average with
stiffer arteries (greater PWV) as compared to controls (Fig. 1 top
panels). Specific clusters of MetS components (HTB, HTBW, GBW,
GTBW) had a disproportionately higher PWV as compared to other
uncommon (occurring in <5% of subjects) MetS clusters
(p < 0.0001). Of note, the above mentioned clusters of MetS com-
ponents did not result in a lower PWV value as compared to
simultaneous alteration of all the five MetS components.
In men, MetS was accompanied by a greater PWV regardless of
all clusters of MetS components (Fig. 1 middle panels). In men, the
clusters TBW, HTBW, and GTBW, GHTBW were associated with an
average of 5% stiffer arteries than were other MetS clusters. No
significant increase in PWV was observed in subjects with alter-
ation in all the five MetS components compared to GBW, GTBW,
HTBW, and GHBW.
In women, MetS was accompanied by greater PWV value
regardless of the clusters of MetS components with the exception of
HTW (PWV 7.84  0.02 vs 7.92  0.11 m/sec in control subjects)
(Fig. 1 middle panels). Subjects with GBW and GTBW clusters
showed, respectively, PWV values similar (p¼ 0.92) or higher (þ5%,
p < 0.01) than observed in subjects with alteration in all the five
MetS components.
Older subjects (>65 years) presented stiffer arteries than
younger subjects, regardless of the cluster of MetS components.
The cluster of MetS components GBW and GTBW were constantly
accompanied by stiffer arteries in both younger and older subjects,
to an extent similar to what was observable in subjects with al-
terations in all the five MetS components (Fig. 1 bottom panels).3.2. Extremely stiff arteries and cluster of MetS components across
populations in the MARE Consortium
We next determined the association of specific clusters of MetS
components with the occurrence of extreme values of PWV,
adopting thewithin cohort 95th PWVpercentile subgroup to define
subjects with extremely stiff arteries. After controlling for age, sex,
smoking, non-HDL cholesterol, and presence of diabetes mellitus,
not all the clusters of MetS components were associated with
extremely stiff arteries as compared to subjects without MetS
(Table 2). Specific clusters of MetS components (TBW, GBW, GTBW)
were accompanied by a 50e80% significantly greater likelihood of
presenting extremely stiff arteriesewhich was even greater than
that associated with the simultaneous alteration in all the fiveMetS
components. This likelihood is comparable to the effect of being 10
years older or of having diabetes mellitus.
Confirmatory analyses were conducted adopting values above
the 95th percentile of PWV distribution in the whole population
rather than the within cohort 95th PWV percentile subgroup to
define subjects with extremely stiff arteries. Consistent with the
primary analyses, TBW, GBW, and GTBW were accompanied by a
50e80% significantly greater likelihood of presenting extremely
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Fig. 1. Least square means (means  SEM) of PWV according to the presence of specific
clusters of MetS components in comparison to subjects without MetS. Left panels:
(top) least square means for PWV levels in the whole population, after controlling for
age, sex, non-HDL cholesterol, smoking, diabetes mellitus, and Study. (middle) least
square means for PWV levels in men and women, after controlling for age, non-HDL
cholesterol, smoking, diabetes mellitus, and Study. (bottom) least square means for
PWV levels in younger and older (>65 years) subjects, after controlling for age, sex,
non-HDL cholesterol, smoking, diabetes mellitus, and Study. Right panels: significance
(p values from ANCOVA) in the difference of PWV between most common cluster of
MetS components in subjects with MetS in comparison with those without MetS, with
least common presentation of MetS, with those with simultaneous alterations in all the
five MetS components.
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components.
3.3. Blood pressure differences across specific clusters of MetS
components in the MARE Consortium
Blood pressure is a major determinant of PWV and it also en-
tries the definition of MetS. The present study was not aimed toexplore potential pathophysiological mechanism but only to
highlight heterogeneity of cluster of MetS in their association with
accelerated arterial aging (stiffer arteries). Yet, comparing blood
pressure levels across MetS clusters and highlighting if those
clusters of MetS components consistently associated with
extremely stiff arteries across populations participating the MARE
Consortium are characterized by higher blood pressure levels
seemed relevant.
Table 3 illustrates blood pressure values across clusters of MetS
components. For instance, TBW, HBW, and TBWhad all significantly
greater systolic and diastolic blood pressure as compared to MetS
clusters occurring in <5% of subjects. Additionally, TBW had sys-
tolic and diastolic blood pressure levels slightly (but not signifi-
cantly) lower than HBW and significantly lower (p < 0.05
Bonferroni post-hoc correction) than HTB. Notably, TBW (OR 1.63;
95% CI 1.08e2.47) but neither HBW (OR 1.27; 95% CI 0.81e2.00) nor
HTB (OR 1.31; 95% CI 0.75e2.30) was associated with a significantly
higher likelihood of having extremely stiff arteries as compared to
MetS clusters occurring in <5% of subjects.
A similar trend in blood pressure values was observed for GBW
or GTBWeclusters of MetS components associated with signifi-
cantly greater likelihood of presenting extremely stiff arteries by
either criteria (above 95th % within cohorts or within the whole
population) as compared to both Control (no MetS) and Other MetS
clusters.
4. Discussion
This large-scale observational study in a large number of sub-
jects from different population-based studies across Europe and US
reveals that what is covered under the current definition of MetS
(NCEP ATP-III) rather represents a mosaic of different phenotypic
conditions with selective associations with arterial aging and
arterial stiffening. Specifically, any cluster of MetS components
identified as MetS, with the exception of HTW, is associated with
stiffer arteries than in control subjects. Overall, TBW, GBW, and
GTBW are consistently associated with significantly stiffer arteries
to an extent similar or greater than observed in subjects with
alteration in all the five MetS componentseeven after controlling
for age, sex, smoking, cholesterol levels, diabetes mellitus, and use
of antihypertensive drugs. Differences in blood pressure levels
amongst the clusters of MetS components do not seem to explain
the reported difference in the likelihood of having accelerated
arterial aging, i.e. extremely stiff arteries.
PWV values differed in men and women, but they provided
comparable differences in the association of MetS altered compo-
nents with stiffer arteries. This finding in a large number of subjects
from different European countries confirmed a previous observa-
tion in the Sardinian population [25].
From the MARE Consortium, we recently reported a gradient of
“risky” clusters of MetS components across European countries and
the US. For instance, the cluster of low HDL cholesterol, elevated
triglycerides, and abdominal obesity (HTW) we found associated
with PWV levels similar to subjects without MetS was far more
common in the cohorts from the US and the Lithuania but had a
much lower prevalence rate in Southern Europe and Sweden [26].
Conversely, the “risky” cluster significantly associated with
extremely stiff arteries (TBW, GBW) showed the highest prevalence
in Sardinia, Italy, in the UK, and in Belgian cohorts and the lowest in
cohorts from Sweden and the US.
Incomplete characterization of the phenotype “Metabolic syn-
drome” may represent a relevant factor explaining the reported
conflicting results on MetS-associated risk of CV disease [30e33].
Speculatively, conflicting results may reflect different prevalence
rates of specific clusters of MetS across populations. For instance, if
Table 2
Specific clusters of MetS components as determinants of extremely stiff arteries e following adjustment for age, sex, diabetes mellitus, non-HDL cholesterol, smoking, and
study site.
Prevalence of MetS cluster PWV above each study specific 95th % PWV above 95th %of the whole population (12.8 m/s)
Whole
population
Subjects
with MetS
Prevalence OR 95% CI p Prevalence OR 95% CI p
Compared to
control (no MetS)
3.8 1.0 3.8 1.0
Age (per 10 years of age) 189 1.80e2.00 0.0001 3.03 2.83e3.25 0.0001
Male Sex 1.35 1.18e1.54 0.0001 1.83 1.59e2.11 0.0001
Current Smoking 1.08 0.98e1.20 0.12 0.86 0.76e0.99 0.05
Diabetes Mellitus 1.62 1.31e2.01 0.0001 1.77 1.42e2.20 0.0001
Non-HDL Cholesterol
(per 40 mg/dl)
1.04 0.98e1.10 0.07 1.15 1.08e1.23 0.0001
Other MetS clusters 3.8 15.5 8.3 1.18 0.86e1.63 8.8 1.13 0.81e1.58
TBW 3.5 14.4 8.0 1.93 1.43e2.60 7.3 1.90 1.37e2.62
HBW 3.1 12.8 7.1 1.50 1.06e2.13 7.7 1.41 0.97e2.04
HTW 1.4 5.9 5.1 1.34 0.78e2.30 2.9 0.72 0.35e1.52
HTB 1.1 4.7 8.4 1.55 0.95e2.51 11.4 1.86 1.18e2.96
HTBW 2.8 11.4 6.1 1.40 0.97e2.00 8.4 2.13 1.53e2.99
GBW 3.1 12.6 14.7 2.24 1.71e2.94 13.6 2.00 1.49e2.68
GTBW 1.9 7.9 12.3 2.14 1.50e3.07 10.2 1.76 1.17e2.64
GHBW 1.2 4.8 12.2 1.88 1.18e2.98 10.9 1.70 1.03e2.82
GHTBW 2.4 9.9 10.5 1.59 1.13e2.25 13.6 2.22 1.58e3.12
Compared to Other
MetS cluster
8.3 1.0 8.8 1.0
Age (per 10 years of age) 189 1.80e2.00 0.0001 3.03 2.83e3.25 0.0001
Male Sex 1.35 1.18e1.54 0.0001 1.83 1.59e2.11 0.0001
Current Smoking 1.08 0.98e1.20 0.12 0.86 0.76e0.99 0.05
Diabetes Mellitus 1.62 1.31e2.01 0.0001 1.77 1.42e2.20 0.0001
Non-HDL Cholesterol
(per 40 mg/dl)
1.04 0.98e1.10 0.07 1.15 1.08e1.23 0.0001
Control (no MetS) 3.8 0.85 0.62e1.16 3.8 0.88 0.64e1.22
TBW 3.5 14.4 8.0 1.63 1.08e2.47 7.3 1.67 1.07e2.59
HBW 3.1 12.8 7.1 1.27 0.81e2.00 7.7 1.24 0.77e2.00
HTW 1.4 5.9 5.1 1.13 0.62e2.05 2.9 0.64 0.29e1.42
HTB 1.1 4.7 8.4 1.31 0.75e2.30 11.4 1.64 0.95e2.84
HTBW 2.8 11.4 6.1 1.18 0.75e1.87 8.4 1.89 1.21e2.97
GBW 3.1 12.6 14.7 1.90 1.33e2.71 13.6 1.76 1.21e2.56
GTBW 1.9 7.9 12.3 1.82 1.20e2.75 10.2 1.55 0.98e2.46
GHBW 1.2 4.8 12.2 1.56 0.96e2.65 10.9 1.50 0.86e2.60
GHTBW 2.4 9.9 10.5 1.35 0.97e2.00 13.6 1.96 1.32e2.90
Clusters of MetS components significantly associated with extremely stiff arteries are highlighted in bold.
A. Scuteri et al. / Atherosclerosis 233 (2014) 654e660658the association between MetS and “hard” or “soft” CV endpoints
(like arterial stiffness, measured as PWV), had been investigated in
a populationwhere HTW had a prevalence twice the averageeas in
the BLSA and the LitHiR Studies, significant association might not
have been seen. The opposite might be expected if the same as-
sociation had been investigated in populations with high preva-
lence of the clusters TBW, GBW, and GTBWeas found in the MARE
Consortium in the SardiNIA or SMART cohorts.
The present study has some limitation. Firstly, we report anal-
ysis from cross-sectional data only. Therefore we cannot conclude
about the role of different clusters of MetS components as potential
predictors of future events (nor was this a goal of the present
study).
Another limitation (and an opportunity for future studies) is
represented by the lack of quantitative standardized data across all
the cohorts participating to the MARE Consortium concerning
lifestyles. For instance, the greater likelihood of having extremely
stiff arteries in subjects with abdominal obesity (larger waist
circumference) may be a consequence of less physical exercise,
greater caloric intake or excessive alcohol consumption rather than
the effect of waist circumference per se’.
Our findings may have significant clinical implications. The
clusters of MetS components we identified as significant de-
terminants of extremely stiff arteries (TBW, GBW, GTBW) may beuseful to identify subjects from subgroups at higher CV risk. This
stratification may occur relatively early in the natural history of CV
disease, considering that the simultaneous alteration in allfiveMetS
components did not result in an increased likelihood of having
accelerated arterial aging, as indexed by extremely stiff arteries.
Furthermore, if selected clusters of MetS components have a
greater detrimental impact on arteries in both men and women, in
younger and older subjects, then more detailed profiling of the
phenotype “Metabolic Syndrome” in different cultural, geographic,
and healthcare context represented in the MARE Consortium may
contribute to identify those combinations of specific factors
resulting in greater individual risk of CV disease. This is in line with
the aims of the “Human Phenome Project” [34].
Moreover, if MetS is accompanied by considerable heterogene-
ity in arterial aging, as indexed by PWV, and this heterogeneity is
observable in both younger and older men and women, then MetS
is not just a theoretical construct, but rather can be envisioned as a
key associated component of the Early Vascular Aging (EVA) Syn-
drome [11]. Additionally, the impact of MetS clusters on the het-
erogeneity of arterial aging process suggests possible preventive
intervention: identifying, assessing, and following up more inten-
sively subjects with a “greater than average” arterial stiffness at any
age may facilitate effective prevention of CV events or cognitive
decline [4e10], even in younger individuals [35].
Table 3
Blood pressure values observed in different MetS clusters. In bold, MetS clusters that showed significantly greater likelihood of being associated with extremely stiff arteries
defined by either criteria (above 95th % within cohorts or within the whole population) as compared to both Control (no MetS) and Other MetS clusterseas illustrated in
Table 2.
SBP DBP
Mean  SD Age- and sex-adjusted (Mean  SEM) Mean  SD Age- and sex-adjusted (Mean  SEM)
Control (no MetS) 129.6  20.0 130.9  0.14 77.6  11.7 77.7  0.09
Other MetS clusters 134.9  19.6 130.9  0.69 78.6  11.8 78.7  0.45
TBW 147.9  14.8 146.1  0.66 88.0  10.6 88.2  0.43
HBW 149.4  16.6 147.5  0.69 86.8  11.7 87.6  0.45
HTW 118.8  12.3 118.3  1.15 88.2  7.4 74.0  0.75
HTB 152.6  16.7 148.6  1.14 84.8  12.5 84.3  0.75
HTBW 150.2  16.4 148.5  0.73 87.6  11.4 88.0  0.47
GBW 151.6  16.5 147.6  0.71 86.6  11.2 87.1  0.46
GTBW 150.7  16.2 148.1  0.90 89.0  11.5 89.0  0.59
GHBW 151.4  15.9 148.5  1.12 85.4  15.4 86.6  0.73
GHTBW 152.5  16.4 149.9  0.78 86.5  11.7 86.9  0.51
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This observational study has shown that different clusters of
components of MetS show different patterns of associations with
arterial aging, indexed as PWV. In other terms, what is covered by
the current definition of MetS is associated with great heteroge-
neity in arterial aging. This heterogeneity may represent the basis
for prevention even in older subjects: identifying, assessing, and
following up more intensively subjects with a “greater than
average” arterial stiffness at any age may facilitate effective pre-
vention of CV events or cognitive decline [4e10].
Notably, specific clusters of MetS components have been found
to be associated with significantly stiffer arteries consistently across
European and US cohortsee.g. in populations differing in genetic
factors, lifestyle or influence of medical treatment. Therefore,
incomplete characterization of the phenotype “Metabolic syn-
drome” may represent a relevant factor explaining the conflicting
results on MetS-associated risk of CV disease reported in previous
studies. Speculatively, conflicting results may reflect different
prevalence rates of specific clusters of MetS across populations.Sources of funding
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None.Novelty and significance
1. What Is New? This is the first collaborative study including both
European and US cohorts to evaluate the association between
clusters of the components included in the Metabolic syndrome
and arterial stiffness, as evaluated by carotid-femoral pulse
wave velocity (PWV). The finding in general indicates that
different cluster of MetS components show shifting associations
with PWV, a core component of the Early Vascular Aging (EVA)
syndrome, thus showing the link between the Metabolic syn-
drome and EVA.
2. What Is Relevant? As the core features of the metabolic syn-
drome are believed to represent target organ damage, as for
example arterial stiffness, it is of importance to see that different
clusters of the components of the Metabolic syndrome
(different phenotypic expressions) show various associations
with arterial stiffness.
3. Summary In reply to: a number of population-based cohorts
from Europe and the US it was shown that a number of com-
ponents of the Metabolic syndrome show different associations
with arterial stiffness, depending on different clusters of these
components. This finding may explain why observational
studies have shown shifting associations with risk of cardio-
vascular endpoints, as population-specific patterns of clusters
may have different associations with arterial stiffness (PWV), an
independent risk marker for cardiovascular disease and all-
cause disease based on meta-analyses.
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